Endothelial dysfunction and mild renal insufficiency in essential hypertension

Circulation

Volumn 110, Issue 7, 2004, Pages 821-825

  Perticone, Francesco ^a   Maio, Raffaele ^a   Tripepi, Giovanni ^b   Zoccali, Carmine ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Acetylcholine; Endothelium; Kidneys

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; CREATININE;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET THERAPY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; VASCULAR DISEASE; VASODILATATION;

ACETYLCHOLINE; ADULT; AGED; ALBUMINURIA; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CREATININE; ENDOTHELIUM, VASCULAR; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; VASODILATION; VASODILATOR AGENTS;

EID: 4143138460     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000138745.21879.27     Document Type: Article

References (33)

1. Ruilope LM, van Veldhuisen DJ, Ritz E, et al. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol. 2001;38:1782-1787.
2. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med. 2001;161:886-891.
3. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol. 1997;20(suppl 2):26-33.
4. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168-175.
5. Perticone F, Maio R, Ceravolo R, et al. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients. Circulation. 1999;99:1991-1996.
6. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
7. Johnson RJ, Herrera-Acosta J, Schreiner GF, et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913-923.
8. Higashi Y, Oshima T, Ozono R, et al. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension. 1995;25:898-902.
9. Higashi Y, Oshima T, Ozono R, et al. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension. 1997;30:252-258.
10. Mimran A, Ribstein J, du Cailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension. 1995;26:937-941.
11. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
12. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
13. Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program: the Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13:180-193.
14. Culleton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56:2214-2219.
15. Ruilope LM, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol. 2001;12:218-225.
16. Leoncini G, Viazzi F, Parodi D, et al. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension. 2003;42:14-18.
17. Fesler P, Du Cailar G, Ribstein J, et al. Left ventricular remodeling and renal function in never-treated essential hypertension. J Am Soc Nephrol. 2003;14:881-887.
18. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
19. Chobanian AV, Bakris GL, Black HR, et al, for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
20. Levey AS, Coresh J, Balk E, et al, for the National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
21. Quiroz Y, Pons H, Gordon KL, et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol. 2001;281:F38-F47.
22. Linder L, Kiowski W, Buhler FR, et al. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
23. Taddei S, Virdis A, Matlei P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
24. Panza JA, Garcia CE, Kilcoyne CM, et al. Impaired endothelium dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
25. John S, Schmieder RL. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens. 2000;18:363-374.
26. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235-1241.
27. Delles C, Jacobi J, Schlaich MP, et al. Assessment of endothelial function of the renal vasculature in human subjects. Am J Hypertens. 2002;15(part 1):3-9.
28. Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.
29. Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948-954.
30. Stuveling EM, Hillege HL, Bakker SJ, et al. C-reactive protein is associated with renal function abnormalities in a nondiabetic population. Kidney Int. 2003;63:654-661.
31. Palatini P. Microalbuminuria in hypertension. Curr Hypertens Rep. 2003;5:208-214.
32. Mimran A. Renal endothelial function in humans. Curr Opin Nephrol Hypertens. 1998;7:149-152.
33. Perico N, Remuzzi G. Nitric oxide and renal perfusion in humans. J Hypertens. 2002;20:391-393.